FR2801507B1 - Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations - Google Patents

Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations

Info

Publication number
FR2801507B1
FR2801507B1 FR9915071A FR9915071A FR2801507B1 FR 2801507 B1 FR2801507 B1 FR 2801507B1 FR 9915071 A FR9915071 A FR 9915071A FR 9915071 A FR9915071 A FR 9915071A FR 2801507 B1 FR2801507 B1 FR 2801507B1
Authority
FR
France
Prior art keywords
reservoir
self
preparation
active ingredient
matrix containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9915071A
Other languages
English (en)
Other versions
FR2801507A1 (fr
Inventor
Michel Sournac
Laurent Liorzou
Joel Bougaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9915071A priority Critical patent/FR2801507B1/fr
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to US10/148,256 priority patent/US20030082227A1/en
Priority to PCT/FR2000/003344 priority patent/WO2001039754A1/fr
Priority to EP00985366A priority patent/EP1233764A1/fr
Priority to CA002392402A priority patent/CA2392402A1/fr
Priority to JP2001541487A priority patent/JP2003515555A/ja
Priority to AU21808/01A priority patent/AU2180801A/en
Publication of FR2801507A1 publication Critical patent/FR2801507A1/fr
Application granted granted Critical
Publication of FR2801507B1 publication Critical patent/FR2801507B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR9915071A 1999-11-30 1999-11-30 Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations Expired - Fee Related FR2801507B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9915071A FR2801507B1 (fr) 1999-11-30 1999-11-30 Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations
PCT/FR2000/003344 WO2001039754A1 (fr) 1999-11-30 2000-11-30 Dispositif transdermique comprenant un reservoir et une matrice contenant le meme principe actif
EP00985366A EP1233764A1 (fr) 1999-11-30 2000-11-30 Dispositif transdermique comprenant un reservoir et une matrice contenant le meme principe actif
CA002392402A CA2392402A1 (fr) 1999-11-30 2000-11-30 Dispositif transdermique comprenant un reservoir et une matrice contenant le meme principe actif
US10/148,256 US20030082227A1 (en) 1999-11-30 2000-11-30 Transdermal device comprising a reservoir and a matrix containing the same active principle
JP2001541487A JP2003515555A (ja) 1999-11-30 2000-11-30 同一有効成分を含有する貯留部と基質部を備えた経皮投与部材
AU21808/01A AU2180801A (en) 1999-11-30 2000-11-30 Transdermal device comprising a reservoir and a matrix containing the same active principle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915071A FR2801507B1 (fr) 1999-11-30 1999-11-30 Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations

Publications (2)

Publication Number Publication Date
FR2801507A1 FR2801507A1 (fr) 2001-06-01
FR2801507B1 true FR2801507B1 (fr) 2003-06-27

Family

ID=9552714

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9915071A Expired - Fee Related FR2801507B1 (fr) 1999-11-30 1999-11-30 Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations

Country Status (7)

Country Link
US (1) US20030082227A1 (fr)
EP (1) EP1233764A1 (fr)
JP (1) JP2003515555A (fr)
AU (1) AU2180801A (fr)
CA (1) CA2392402A1 (fr)
FR (1) FR2801507B1 (fr)
WO (1) WO2001039754A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10137405A1 (de) 2001-07-31 2003-02-20 Beiersdorf Ag Verfahren zur kontinuierlichen Herstellung und Beschichtung von Selbstklebemassen auf Basis von SBC mit mindestens einem pharmazeutischen Wirkstoff
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
WO2004098472A1 (fr) * 2002-08-30 2004-11-18 Watson Pharmaceuticals, Inc. Systemes et techniques d'administration transdermique
US20040259852A1 (en) 2003-06-18 2004-12-23 White Hillary D. Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
US8883769B2 (en) 2003-06-18 2014-11-11 White Mountain Pharma, Inc. Methods for the treatment of fibromyalgia and chronic fatigue syndrome
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
RU2497679C2 (ru) * 2008-10-02 2013-11-10 Милан Инк. Способ получения многослойного клеящегося ламинированного материала
US9642863B2 (en) 2010-11-18 2017-05-09 White Mountain Pharma, Inc. Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein
JP6893086B2 (ja) 2013-03-13 2021-06-23 エーブリー デニソン コーポレイション 接着特性の向上

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
DE19844079A1 (de) * 1998-05-22 1999-11-25 Novosis Pharma Ag Biphasische Transdermalsysteme

Also Published As

Publication number Publication date
US20030082227A1 (en) 2003-05-01
EP1233764A1 (fr) 2002-08-28
JP2003515555A (ja) 2003-05-07
AU2180801A (en) 2001-06-12
CA2392402A1 (fr) 2001-06-07
WO2001039754A1 (fr) 2001-06-07
FR2801507A1 (fr) 2001-06-01

Similar Documents

Publication Publication Date Title
FR2801507B1 (fr) Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations
EP1300719A4 (fr) Dispositif d'affichage a matrice active, procede de commande associe et element d'affichage
FR2779438B1 (fr) Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
EP1362788A3 (fr) Dispositifs, systèmes et méthodes permettant de contenir de d'utiliser des solutions liquides
BR0303339A (pt) Sistema de radiocomunicação, dispositivo e método de radiocomunicação para administrar uma rede sem fio, e para conduzir radiocomunicação em uma rede sem fio, e, programa de computador escrito em um formato legìvel por computador
DK1176961T3 (da) Nikotinafgivende systemer
NO981638L (no) Legemiddel- avgivelsesanordning for to eller flere aktive forbindelser
DE69021513D1 (de) Anzeigevorrichtung mit aktiver Matrix.
FR2791774B1 (fr) Transducteur, accelerometre incorporant ledit transducteur et destine notamment a un dispositif medical implantable
FR2680368B1 (fr) Alpha-glycosyl-quercetine, son procede de preparation et ses utilisations.
WO2005004837A8 (fr) Dispositifs d'administration de medicaments par voie intravaginale
DE69109321D1 (de) Anzeigevorrichtung mit aktiver Matrix.
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
DE59904843D1 (de) Vorrichtung zum anlocken und fangen von insekten
YU45301A (sh) Sistemi za oslobađanje leka kroz kožu
BR9812553B1 (pt) formulação medicamentosa em pélete de difusão controlada e em um sistema matriz.
FR2839451B1 (fr) Compose comprenant un polymere, un espaceur et un principe actif, composition contenant ce compose et utilisations
ITFI990055A0 (it) Un dispositivo per la somministrazione per via transcutanea di molecole contenute in un prodotto veicolante relativamente viscoso,
DE68917651D1 (de) Aktiv-Matrix-Anzeigevorrichtung.
FR2799612B1 (fr) Dispositif de diffusion de produits volatils de traitement dans le sol
ATE278395T1 (de) Transdermales pflaster, enthaltend mindestens einen die blutfettwerte beeinflussenden wirkstoff
FR2795148B1 (fr) Dispositif actif d'amortissement
FR2826548B1 (fr) Particule comprenant une matrice et au moins un agent bioactif, son procede de preparation et ses applications
AU2002328873A1 (en) Dosage forms comprising particles containing active ingredient for application on the skin or mucous membrane

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060731